查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654194

十二指腸潰瘍治療市場規模、佔有率、趨勢分析報告：按治療、給藥途徑、通路、地區和細分市場進行預測，2025-2030 年

Duodenal Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Proton Pump Inhibitors, H2 Antagonists), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

十二指腸潰瘍治療市場的成長與趨勢

預計到 2030 年全球十二指腸潰瘍治療市場規模將達到 55.4 億美元，2025 年至 2030 年的複合年成長率為 3.2%。

該市場包括專注於十二指腸潰瘍（發生在十二指腸內壁的潰瘍）的管理和治療的各種組成部分。

藥物治療對十二指腸潰瘍治療市場至關重要。這些藥物包括質子幫浦抑制劑 (PPI)、組織胺受體拮抗劑 (H2RA)、針對幽門螺旋桿菌感染的抗生素、黏膜保護劑和抗酸藥。這些藥物可以減少胃酸分泌，消除細菌病原體，增強黏膜防禦能力，並中和胃酸。這種治療方法可以促進潰瘍癒合，同時緩解腹脹、疼痛和不適。

由於行動應用程式、遠端醫療平台和遠端監控工具等數位健康解決方案的採用，市場正在經歷顯著成長。這些技術實現了個人化護理管理、即時症狀追蹤和增強病人參與。此外，人工智慧（AI）演算法正在用於分析大型資料集，以促進改善治療結果和早期發現潰瘍問題。

十二指腸潰瘍治療市場報告重點

  • 由於胃腸道疾病的發生率不斷上升，尤其是老年人群體，他們容易患十二指腸潰瘍等疾病，因此質子幫浦抑制劑領域在 2024 年佔據了市場主導地位，收入佔有率為 52.1%。
  • 預計口服藥物領域將在 2024 年佔據最大的收入佔有率，這主要得益於患者對易於操作且方便的非侵入性治療方案的偏好。
  • 零售藥局部門在 2024 年佔據了最大的收益佔有率，這要歸功於零售藥局為尋求非處方十二指腸潰瘍藥物的患者提供的便利性和可及性。
  • 受先進的醫療基礎設施和消費者高水準的醫療保健支出的推動，北美十二指腸潰瘍治療市場預計將在 2024 年佔據 39.5% 的最高收益佔有率。
  • 預計預測期內醫院藥局部門將以複合年成長率大幅成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 十二指腸潰瘍治療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第 4 章十二指腸潰瘍治療市場：治療業務分析

  • 2024 年和 2030 年治療市場佔有率
  • 治療細分儀表板
  • 2018 年至 2030 年按療法分類的市場規模、預測與趨勢分析
  • 質子幫浦抑制劑
  • H2 拮抗劑
  • 抗生素
  • 其他

5. 十二指腸潰瘍治療市場：給藥途徑業務分析

  • 2024 年及 2030 年給藥途徑市場佔有率
  • 給藥途徑細分儀表板
  • 2018 年至 2030 年按給藥途徑分類的市場規模、預測和趨勢分析
  • 口服
  • 腸外

6. 十二指腸潰瘍治療市場：通路業務分析

  • 分銷通路市場佔有率，2024 年和 2030 年
  • 分銷通路細分儀表板
  • 2018 年至 2030 年按分銷管道分類的市場規模、預測和趨勢分析
  • 醫院藥房
  • 零售藥局
  • 其他

第 7 章十二指腸潰瘍治療市場：按地區分類的估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • GSK plc.
    • Pfizer Inc.
    • Novartis AG
    • Merck KGaA
    • NIHON GENERIC Co., Ltd.
    • Abbott
    • AstraZeneca
    • Bristol-Myers Squibb Company
    • Takeda Pharmaceutical Company Limited.
    • Eisai Co., Ltd.
Product Code: GVR-4-68040-446-2

Duodenal Ulcer Treatment Market Growth & Trends:

The global duodenal ulcer treatment market size is anticipated to reach USD 5.54 billion in 2030 and is anticipated to grow at a CAGR of 3.2% from 2025 to 2030. The market encompasses a range of elements focused on the management and treatment of duodenal ulcers, which are sores that occur in the lining of the duodenum.

Pharmacological treatments are crucial to the duodenal ulcer treatment market. These medications include proton pump inhibitors (PPIs), histamine receptor antagonists (H2RAs), and antibiotics targeting Helicobacter pylori infections, mucosal protectants, and antacids. These medications reduce gastric acid production, eradicate bacterial pathogens, enhance mucosal defense, or neutralize stomach acid. This therapeutic approach alleviates bloating, abdominal pain, and discomfort while accelerating ulcer healing.

The market is experiencing significant growth due to the incorporation of digital health solutions such as mobile apps, telemedicine platforms, and remote monitoring tools. These technologies enable personalized treatment management, real-time symptom tracking, and enhanced patient engagement. Additionally, artificial intelligence (AI) algorithms are being employed to analyze large datasets, which improves treatment outcomes and facilitates early detection of ulcer issues.

Duodenal Ulcer Treatment Market Report Highlights:

  • The proton pump inhibitors segment dominated the market with a revenue share of 52.1% in 2024, driven by the increasing prevalence of gastrointestinal disorders, particularly among the aging population, who are more susceptible to conditions such as duodenal ulcers
  • The oral segment dominated the market with the largest revenue share in 2024, driven by patient preference for non-invasive treatment options that offer ease of administration and convenience
  • The retail pharmacies segment dominated the market with the largest revenue share in 2024, fueled by the accessibility and convenience that retail pharmacies provide for patients seeking over-the-counter medications for duodenal ulcers
  • North America duodenal ulcer treatment market held the highest revenue share of 39.5% in 2024, fueled by the advanced healthcare infrastructure and high levels of healthcare spending among consumers
  • The hospital pharmacies segment is projected to grow at the significant CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Duodenal Ulcer Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Duodenal Ulcer Treatment Market: Treatment Business Analysis

  • 4.1. Treatment Market Share, 2024 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Billion)
  • 4.4. Proton Pump Inhibitors
    • 4.4.1. Proton Pump Inhibitors Market, 2018 - 2030 (USD Billion)
  • 4.5. H2 Antagonists
    • 4.5.1. H2 Antagonists Market, 2018 - 2030 (USD Billion)
  • 4.6. Antibiotics
    • 4.6.1. Antibiotics Market, 2018 - 2030 (USD Billion)
  • 4.7. Other
    • 4.7.1. Other Market, 2018 - 2030 (USD Billion)

Chapter 5. Duodenal Ulcer Treatment Market: Route of Administration Business Analysis

  • 5.1. Route of Administration Market Share, 2024 & 2030
  • 5.2. Route of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Billion)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2018 - 2030 (USD Billion)
  • 5.5. Parenteral
    • 5.5.1. Parenteral Market, 2018 - 2030 (USD Billion)

Chapter 6. Duodenal Ulcer Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Billion)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Billion)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Billion)
  • 6.6. Other
    • 6.6.1. Other Market, 2018 - 2030 (USD Billion)

Chapter 7. Duodenal Ulcer Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Europe
    • 7.5.1. Europe Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. MEA
    • 7.8.1. MEA Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. GSK plc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Pfizer Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Novartis AG
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Merck KGaA
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. NIHON GENERIC Co., Ltd.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Abbott
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. AstraZeneca
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Bristol-Myers Squibb Company
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Takeda Pharmaceutical Company Limited.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Eisai Co., Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global duodenal ulcer treatment market, by region, 2018 - 2030 (USD Billion)
  • Table 4. Global duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 5. Global duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 6. Global duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 7. North America duodenal ulcer treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 8. North America duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 9. North America duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 10. North America duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 11. U.S. duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 12. U.S. duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 13. U.S. duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 14. Canada duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 15. Canada duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 16. Canada duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 17. Mexico duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 18. Mexico duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 19. Mexico duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 20. Europe duodenal ulcer treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 21. Europe duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 22. Europe duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 23. Europe duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 24. UK duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 25. UK duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 26. UK duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 27. Germany duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 28. Germany duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 29. Germany duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 30. France duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 31. France duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 32. France duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 33. Italy duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 34. Italy duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 35. Italy duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 36. Spain duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 37. Spain duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 38. Spain duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 39. Denmark duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 40. Denmark duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 41. Denmark duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 42. Sweden duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 43. Sweden duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 44. Sweden duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 45. Norway duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 46. Norway duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 47. Norway duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 48. Asia Pacific duodenal ulcer treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 49. Asia Pacific duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 50. Asia Pacific duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 51. Asia Pacific duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 52. Japan duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 53. Japan duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 54. Japan duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 55. China duodenal ulcer treatment market, by treatment, 2018-2030 (USD Billion)
  • Table 56. China duodenal ulcer treatment market, by route of administration, 2018-2030 (USD Billion)
  • Table 57. China duodenal ulcer treatment market, by distribution channel, 2018-2030 (USD Billion)
  • Table 58. India duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 59. India duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 60. India duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 61. South Korea duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 62. South Korea duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 63. South Korea duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 64. Australia duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 65. Australia duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 66. Australia duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 67. Thailand duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 68. Thailand duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 69. Thailand duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 70. Latin America duodenal ulcer treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 71. Latin America duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 72. Latin America duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion
  • Table 73. Latin America duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion
  • Table 74. Brazil duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 75. Brazil duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 76. Brazil duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 77. Argentina duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 78. Argentina duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 79. Argentina duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 80. Middle East & Africa duodenal ulcer treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 81. Middle East & Africa duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 82. Middle East & Africa duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 83. Middle East & Africa duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 84. South Africa duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 85. South Africa duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 86. South Africa duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 87. Saudi Arabia duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 88. Saudi Arabia duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 89. Saudi Arabia duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 90. UAE duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 91. UAE duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 92. UAE duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 93. Kuwait duodenal ulcer treatment market, by treatment, 2018 - 2030 (USD Billion)
  • Table 94. Kuwait duodenal ulcer treatment market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 95. Kuwait duodenal ulcer treatment market, by distribution channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Duodenal ulcer treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment outlook (USD Billion)
  • Fig. 10 Route of administration outlook (USD Billion)
  • Fig. 11 Distribution channel outlook (USD Billion)
  • Fig. 12 Competitive landscape
  • Fig. 13 Duodenal ulcer treatment market dynamics
  • Fig. 14 Duodenal ulcer treatment market: Porter's five forces analysis
  • Fig. 15 Duodenal ulcer treatment market: PESTLE analysis
  • Fig. 16 Duodenal ulcer treatment market: Treatment segment dashboard
  • Fig. 17 Duodenal ulcer treatment market: Treatment market share analysis, 2024 & 2030
  • Fig. 18 Proton pump inhibitors market, 2018 - 2030 (USD Billion)
  • Fig. 19 H2 antagonists market, 2018 - 2030 (USD Billion)
  • Fig. 20 Antibiotics market, 2018 - 2030 (USD Billion)
  • Fig. 21 Other market, 2018 - 2030 (USD Billion)
  • Fig. 22 Duodenal ulcer treatment market: Route of administration segment dashboard
  • Fig. 23 Duodenal ulcer treatment market: Route of administration market share analysis, 2024 & 2030
  • Fig. 24 Oral market, 2018 - 2030 (USD Billion)
  • Fig. 25 Parenteral market, 2018 - 2030 (USD Billion)
  • Fig. 26 Duodenal ulcer treatment market: Distribution channel segment dashboard
  • Fig. 27 Duodenal ulcer treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 28 Hospital pharmacies market, 2018 - 2030 (USD Billion)
  • Fig. 29 Retail pharmacies market, 2018 - 2030 (USD Billion)
  • Fig. 30 Other market, 2018 - 2030 (USD Billion)
  • Fig. 31 Duodenal ulcer treatment market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 40 Europe duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 45 France country dynamics
  • Fig. 46 France duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 55 Norway country dynamics
  • Fig. 56 Norway duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 57 Asia Pacific duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 60 China country dynamics
  • Fig. 61 China duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 62 India country dynamics
  • Fig. 63 India duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 64 South Korea country dynamics
  • Fig. 65 South Korea duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 66 Australia country dynamics
  • Fig. 67 Australia duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 70 Latin America duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 75 MEA duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait duodenal ulcer treatment market, 2018 - 2030 (USD Billion)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework